JPS6338979B2 - - Google Patents
Info
- Publication number
- JPS6338979B2 JPS6338979B2 JP54051579A JP5157979A JPS6338979B2 JP S6338979 B2 JPS6338979 B2 JP S6338979B2 JP 54051579 A JP54051579 A JP 54051579A JP 5157979 A JP5157979 A JP 5157979A JP S6338979 B2 JPS6338979 B2 JP S6338979B2
- Authority
- JP
- Japan
- Prior art keywords
- propane
- dimethylphenoxy
- group
- general formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 33
- -1 phenylsulfonyloxy group Chemical class 0.000 claims description 15
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 7
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 125000000852 azido group Chemical class *N=[N+]=[N-] 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- TVPPZASKIXGUJQ-UHFFFAOYSA-N n-propyl azide Chemical compound CCCN=[N+]=[N-] TVPPZASKIXGUJQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- QWWBZHDIGCDTLY-UHFFFAOYSA-N propyl 2,2,2-trichloroacetate Chemical compound CCCOC(=O)C(Cl)(Cl)Cl QWWBZHDIGCDTLY-UHFFFAOYSA-N 0.000 claims 1
- JTTWNTXHFYNETH-UHFFFAOYSA-N propyl 4-methylbenzenesulfonate Chemical compound CCCOS(=O)(=O)C1=CC=C(C)C=C1 JTTWNTXHFYNETH-UHFFFAOYSA-N 0.000 claims 1
- DKORSYDQYFVQNS-UHFFFAOYSA-N propyl methanesulfonate Chemical compound CCCOS(C)(=O)=O DKORSYDQYFVQNS-UHFFFAOYSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 30
- 238000000034 method Methods 0.000 description 21
- 239000000203 mixture Substances 0.000 description 19
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 10
- HJFXAWKTYCNUQJ-UHFFFAOYSA-N 2-(2-azidopropoxy)-1,3-dimethylbenzene Chemical compound [N-]=[N+]=NC(C)COC1=C(C)C=CC=C1C HJFXAWKTYCNUQJ-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000001294 propane Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- QFOWJPBDGSGFEJ-UHFFFAOYSA-N 1-(2,6-dimethylphenoxy)propan-2-ol Chemical compound CC(O)COC1=C(C)C=CC=C1C QFOWJPBDGSGFEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- SCDVGDQWXWIKEA-UHFFFAOYSA-N 1-(2,6-dimethylphenoxy)propan-2-yl 4-methylbenzenesulfonate Chemical compound CC1=C(OCC(C)OS(=O)(=O)C2=CC=C(C=C2)C)C(=CC=C1)C SCDVGDQWXWIKEA-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000005660 chlorination reaction Methods 0.000 description 5
- VLPIATFUUWWMKC-UHFFFAOYSA-N mexiletine Chemical compound CC(N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-UHFFFAOYSA-N 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- NFEIBWMZVIVJLQ-UHFFFAOYSA-N mexiletine hydrochloride Chemical compound [Cl-].CC([NH3+])COC1=C(C)C=CC=C1C NFEIBWMZVIVJLQ-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- VLPIATFUUWWMKC-SNVBAGLBSA-N (2r)-1-(2,6-dimethylphenoxy)propan-2-amine Chemical compound C[C@@H](N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-SNVBAGLBSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229960003404 mexiletine Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- WLAXWUTWXLCXNM-UHFFFAOYSA-N 1-(2,6-dimethylphenoxy)propan-2-yl 2,2,2-trichloroacetate Chemical compound CC1=C(OCC(C)OC(C(Cl)(Cl)Cl)=O)C(=CC=C1)C WLAXWUTWXLCXNM-UHFFFAOYSA-N 0.000 description 2
- XLJQPXVBQNJNLW-UHFFFAOYSA-N 1-methylaziridine Chemical compound CN1CC1 XLJQPXVBQNJNLW-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- VQFAIAKCILWQPZ-UHFFFAOYSA-N bromoacetone Chemical compound CC(=O)CBr VQFAIAKCILWQPZ-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NWINJJIRFPNRDA-UHFFFAOYSA-N 1-(2,6-dimethylphenoxy)propan-2-yl methanesulfonate Chemical compound CS(=O)(=O)OC(C)COC1=C(C)C=CC=C1C NWINJJIRFPNRDA-UHFFFAOYSA-N 0.000 description 1
- QWBBPBRQALCEIZ-UHFFFAOYSA-N 2,3-dimethylphenol Chemical compound CC1=CC=CC(O)=C1C QWBBPBRQALCEIZ-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- IVDYILJMWVOXRG-UHFFFAOYSA-N n,n-diethylethanamine;propane Chemical compound CCC.CCN(CC)CC IVDYILJMWVOXRG-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 1
- 229940031826 phenolate Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- PYNUOAIJIQGACY-UHFFFAOYSA-N propylazanium;chloride Chemical compound Cl.CCCN PYNUOAIJIQGACY-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- PVFOMCVHYWHZJE-UHFFFAOYSA-N trichloroacetyl chloride Chemical compound ClC(=O)C(Cl)(Cl)Cl PVFOMCVHYWHZJE-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 208000003663 ventricular fibrillation Diseases 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
【発明の詳細な説明】
本発明は一般式()
(式中、Aはペルハロゲン化低級アルキルカル
ボニルオキシ基、低級アルキルスルホニルオキシ
基、低級アルキル置換フエニルスルホニルオキシ
基またはアジド基を示す)の新規なフエニルエー
テル化合物及び同化合物の製法に関する。本発明
はまた上記化合物を有用な治療薬剤である1―
(2,6―ジメチルフエノキシ)―2―アミノ―
プロパンに転換する方法にも関する。[Detailed Description of the Invention] The present invention relates to the general formula () (In the formula, A represents a perhalogenated lower alkylcarbonyloxy group, a lower alkylsulfonyloxy group, a lower alkyl-substituted phenylsulfonyloxy group, or an azido group) and a method for producing the same. The present invention also describes the above compounds as useful therapeutic agents.
(2,6-dimethylphenoxy)-2-amino-
It also concerns how to convert it to propane.
一般式()の新規な化合物は有用な生物活性
を有し、更に心室性不整脈の治療に用いられる化
合物、1―(2,6―ジメチルフエノキシ)―2
―アミノ―プロパン塩酸塩(メキシレチン
(Mexiletine))の合成上の重要な中間体として
用いることができる。 The novel compounds of the general formula () have useful biological activity and are also compounds used in the treatment of ventricular arrhythmias, 1-(2,6-dimethylphenoxy)-2
-Can be used as an important intermediate in the synthesis of amino-propane hydrochloride (Mexiletine).
周知のように、メキシレチン塩基及びその医薬
として許容できる酸付加塩は心室性不整脈状態に
おいて有益な作用を示し、かつ虚血性心臓障害、
心筋梗塞、心室細動及び頻脈の治療に特に有利に
適用できる(「Brit.Heart J.」35,558,559
(1973);「Lancet」1973/,339―403,404―
407;「Brit.J.Clin.Pharmacol.」1,86―87,229
―232(1974))。 As is well known, mexiletine base and its pharmaceutically acceptable acid addition salts exhibit beneficial effects in ventricular arrhythmia conditions and in ischemic heart disorders,
It can be applied particularly advantageously to the treatment of myocardial infarction, ventricular fibrillation and tachycardia ("Brit.Heart J." 35 , 558, 559
(1973); “Lancet” 1973/ , 339―403, 404―
407; "Brit.J.Clin.Pharmacol." 1 , 86-87, 229
-232 (1974)).
1―(2,6―ジメチルフエノキシ)―2―ア
ジド―プロパン(式()中、A=アジド)の抗
細動(Camtifibrillant)効果は〔B.Vargrafting
及びJ.D.Coignet(「Eur.J.of Pharmacol.」6,49
―55(1969))の方法に従つて測つたときED50=
150mg/Kg(経口)の〕メキシレチンの同効果と
実質的に同じである。この化合物はS.Irwinの方
法(「Science」136,123(1962))によつて証明さ
れるように好適な鎮静作用も有する。この後者の
試験では1―(2,6―ジメチルフエノキシ)―
2―トシルオキシ―プロパン(式()中、A=
トシルオキシ)も有効な鎮静剤であることが判つ
た。 The anti-fibrillant effect of 1-(2,6-dimethylphenoxy)-2-azido-propane (in formula (), A = azide) is [B. Vargrafting
and JDCoignet (“Eur.J.of Pharmacol.” 6, 49
-55 (1969)) ED 50 =
The effect is substantially the same as that of mexiletine at 150 mg/Kg (oral). This compound also has a suitable sedative effect as demonstrated by the method of S. Irwin (Science 136 , 123 (1962)). In this latter test, 1-(2,6-dimethylphenoxy)-
2-tosyloxy-propane (in formula (), A=
tosyloxy) was also found to be an effective sedative.
一般式()の新規な化合物は当業界でよく知
られた方法により経口もしくは非経口投与用の医
薬組成物に転換できる。この医薬組成物は錠剤、
被覆錠剤、カプセル剤、注射用溶液もしくは懸濁
液、坐剤等のような固形、半固形もしくは液体製
剤であつてもよく、そして活性成分の外に慣用の
医薬として許容され得る担体、希釈剤及び/もし
くは補助剤を含んでいてもよい。担体もしくは希
釈剤として、例えば、水、無毒な有機溶媒、鉱油
もしくは植物油、デンプン、ラクトース、ケイソ
ウ土、ココアバター等を用いることができる。補
助剤の々ち、次のものを挙げることができる:
(微結晶セルロース、アラビアゴム及びゼラチン
のような)結合剤、(アルギン酸及びトウモロコ
シデンプンのような)崩壊剤、(ステアリン酸マ
グネシウムのような)滑沢剤、(スクロースのよ
うな)香味剤、(アスコルビン酸のような)酸化
防止剤、保存剤、界面活性剤及び(塩化ナトリウ
ムのような)浸透圧調整用塩類。 The novel compounds of general formula () can be converted into pharmaceutical compositions for oral or parenteral administration by methods well known in the art. This pharmaceutical composition includes tablets,
It may be a solid, semi-solid or liquid preparation, such as a coated tablet, capsule, injectable solution or suspension, suppository, etc., and, in addition to the active ingredient, customary pharmaceutically acceptable carriers, diluents, etc. and/or may contain auxiliary agents. As carriers or diluents, for example, water, non-toxic organic solvents, mineral or vegetable oils, starch, lactose, diatomaceous earth, cocoa butter and the like can be used. Among the adjuvants, the following may be mentioned:
Binders (such as microcrystalline cellulose, gum arabic and gelatin), disintegrants (such as alginic acid and corn starch), lubricants (such as magnesium stearate), flavoring agents (such as sucrose), ( antioxidants (such as ascorbic acid), preservatives, surfactants, and osmotic salts (such as sodium chloride).
以上に述べたように、一般式()の新規な化
合物は有益な治療薬剤として1―(2,6―ジメ
チルフエノキシ)―2―アミノ―プロパンの合成
において出発物質としても使用できる。以下にこ
の化合物の公知合成法をまず討議し、そして次に
新規な製造方法及びその利点を述べよう。 As mentioned above, the novel compounds of general formula () can also be used as starting materials in the synthesis of 1-(2,6-dimethylphenoxy)-2-amino-propane as a valuable therapeutic agent. In the following, we will first discuss the known synthesis methods for this compound, and then describe the new method of preparation and its advantages.
1―(2,6―ジメチルフエノキシ)―2―ア
ミノ―プロパンの製造に関しては英国特許明細書
第1205958号に数方法が開示してある。 Several methods are disclosed in GB 1205958 for the production of 1-(2,6-dimethylphenoxy)-2-amino-propane.
これらの方法の一つによれば、目的生成物は一
般式()
(式中、Bは1もしくは2個の保護基を有する
アミノ基である)の化合物の保護基を除去するこ
とによつて製造される。前記引例にはこれらの保
護基としてベンジル、フタリル、トルエンスルホ
ニル、及びホルミル基を挙げているが、実施例で
はベンジル基の割裂にしかふれていない。 According to one of these methods, the desired product has the general formula () (wherein B is an amino group having one or two protecting groups) by removing the protecting groups of the compound. The cited reference mentions benzyl, phthalyl, toluenesulfonyl, and formyl groups as these protective groups, but the Examples only mention the cleavage of the benzyl group.
一般式()の出発物質は上記英国特許明細書
によれば一般式()
(式中、Halはハロゲン原子を示す)の化合物
を一般式()
B−H ()
(式中、Bは上記定義の通りである)の化合物
と反応させて製造できる。 According to the above British patent specification, the starting material of the general formula () is of the general formula () (In the formula, Hal represents a halogen atom.) It can be produced by reacting a compound of the general formula () B-H () (In the formula, B is as defined above).
一般式()の化合物はまた式()
のケトンを還元条件下において一般式()
H2N−Q ()
(式中、Qは前述置換基B中に存在する保護基
を示す)の化合物と反応させることによつても製
造できる(英国特許明細書第1205958号)。 Compounds of general formula () are also compounds of formula () ( British Patent Specification No. 1205958).
上記方法では次のような不利益がある:即ち、
一般式()(式中、当該保護基はベンジルであ
る、)の化合物の水添付加反応は最低5気圧下80
℃でしか進行せず、そして中位の収率(約50ない
し55%)でしか所望アミノ化合物が生成されな
い。 The above method has the following disadvantages:
The addition reaction with water of the compound of the general formula () (in which the protecting group is benzyl) is carried out under a minimum of 5 atm.80
℃ and produces the desired amino compound in only moderate yields (approximately 50 to 55%).
更に、出発物質そのものを製造するのが難し
い。一般式()の化合物を一般式()の化合
物と反応させることによつて一般式()の化合
物を製造するとき、ベンジルアミンの反応性が高
いために二重アルキル化反応も生じて結果的に式
()
のビス誘導体が副生成物として生成する。その上
に、過剰のアミンによる反応の進行で付加副生成
物の生成を来たすのでハロゲン化水素酸塩の除去
を行う。これらの生成物そのものを精製するのが
困難であり、このことが更に収率を低下させてし
まう。 Furthermore, the starting materials themselves are difficult to manufacture. When a compound of general formula () is prepared by reacting a compound of general formula () with a compound of general formula (), a double alkylation reaction also occurs due to the high reactivity of benzylamine, resulting in expression () A bis derivative of is produced as a by-product. In addition, the hydrohalide salt is removed since the reaction progresses with excess amine, resulting in the formation of addition by-products. These products themselves are difficult to purify, which further reduces yields.
一般式()の化合物または式()のケトン
を還元条件下でしかるべく保護したアミンと反応
させることによつても製造できる。しかしなが
ら、この方法は引例の特許明細書には例示されて
いない。 They can also be prepared by reacting compounds of general formula () or ketones of formula () with appropriately protected amines under reducing conditions. However, this method is not exemplified in the cited patent specification.
式()のケトンそのものを製造するにおい
て、この化合物が非常に毒性の高い物質である、
クロロアセトンもしくはブロモアセトンの塩と
2,6―ジメチルフエノールの塩を反応させるこ
とによつて合成されるので付加的な困難事が生じ
る(N.I.Sax「Handbook of Dangerous
Materials」Reinhold Publ.Corp.,New York,
1951,94頁)。 In producing the ketone of formula () itself, this compound is a highly toxic substance,
Additional difficulties arise because they are synthesized by reacting a salt of chloroacetone or bromoacetone with a salt of 2,6-dimethylphenol (NISax Handbook of Dangerous
Materials” Reinhold Publ.Corp., New York,
1951, p. 94).
英国特許明細書第1205958号ではまたフタリル、
トルエンスルホニル及びホルミル保護基の利用を
述べているが、しかしながら、これらの方法は例
によつて説明されていない。 British Patent Specification No. 1205958 also describes phthalyl,
The use of toluenesulfonyl and formyl protecting groups is mentioned, however, these methods are not illustrated by example.
英国特許明細書第1205958号に開示されている
別の方法によれば、式()のケトンをまずアン
モニア、ヒドロキシルアミンもしくはヒドラジン
で処理し、そして得られた一般式()
(式中、Yは水素、ヒドロキシもしくはアミノ
を示す)の化合物を接触水添で、又は適当な金属
水素化物の錯体のいずれか一方で還元して1―
(2,6―ジメチルフエノキシ)―2―アミノ―
プロパンを得る。 According to another method disclosed in British Patent Specification No. 1205958, a ketone of formula () is first treated with ammonia, hydroxylamine or hydrazine and the resulting general formula () (wherein Y represents hydrogen, hydroxy or amino) is reduced to 1-
(2,6-dimethylphenoxy)-2-amino-
Get propane.
この方法にもやはりいくつかの不利益がある。
この水添付加反応は中位の収率でしか実施できな
く(オキシムについては51.5%でイミンについて
は44.3%であり、そしてヒドラゾンの還元の例は
ない)、更に上で述べたように式()の出発ケ
トンを製造するのは難しい。 This method also has some disadvantages.
This water addition reaction can only be carried out with moderate yields (51.5% for oximes and 44.3% for imines, and there are no examples of reduction of hydrazones), and as mentioned above, the formula ( ) is difficult to produce.
上記英国特許明細書に開示されている別の方法
によれば、2,6―ジメチルフエノールを1―メ
チル―アジリジンと反応させることによつて2,
6―ジメチルフエノールから1―(2,6―ジメ
チルフエノキシ)―2―アミノ―プロパンが製造
できる。しかしこの方法に関する例は明細書中に
示されていない。 According to another method disclosed in the above-mentioned British patent specification, 2,6-dimethylphenol is reacted with 1-methyl-aziridine.
1-(2,6-dimethylphenoxy)-2-amino-propane can be produced from 6-dimethylphenol. However, no examples of this method are given in the specification.
この方法の不利益は1―メチル―アジリジンを
利用することにある。この化合物はエチレンイミ
ンのように極端に有害ではなく(参照N.I.Sax
「Handbook of Dangerous Materials」,
Reinhold Publ.Corp.,New York,1951,328
頁)、更に非常に重合化しやすい。この重合化反
応はこの混合物を加熱するとき、もしくは極微量
の(フエノールのような)酸の効果によつてさえ
生じる。 The disadvantage of this method is that it utilizes 1-methyl-aziridine. This compound is not extremely harmful like ethyleneimine (see NISax
“Handbook of Dangerous Materials”
Reinhold Publ. Corp., New York, 1951, 328
Page), and is also very susceptible to polymerization. The polymerization reaction occurs when the mixture is heated or even by the effect of trace amounts of acids (such as phenols).
英国特許明細書第1205958号に開示された更に
別の方法では出発物質として2,6―ジメチルフ
エノールの塩を用いる。この塩は一般式()
(式中、Zはハロゲンのような反応性エステル
基である)の化合物と反応させる。この方法も例
示されていない。 Yet another method disclosed in GB 1205958 uses a salt of 2,6-dimethylphenol as the starting material. This salt has the general formula () (wherein Z is a reactive ester group such as a halogen). This method is also not exemplified.
この方法の不利益は製造することが難しく、か
つ二量化がかなり容易であり、それによつてピペ
ラジン誘導体を形成する式()の反応物質を使
用することにある。 The disadvantage of this process lies in the use of reactants of formula () which are difficult to prepare and are rather easy to dimerize, thereby forming piperazine derivatives.
1―(2,6―ジメチルフエノキシ)―2―ヒ
ドロキシ―プロパンは米国特許明細書第3979460
号に不所望な副生成物として挙げられているが、
これは4,4′―ヒドロキシ―3,3′―テトラメチ
ル―ジフエニルスルフイドの合成において収率12
%で生成される。この特許明細書にはヒドロキシ
化合物の物理定数が示されていない。 1-(2,6-dimethylphenoxy)-2-hydroxy-propane is disclosed in U.S. Patent No. 3979460.
Although it is listed as an undesirable by-product in the
This results in a yield of 12 in the synthesis of 4,4'-hydroxy-3,3'-tetramethyl-diphenyl sulfide.
Generated in %. Physical constants of hydroxy compounds are not given in this patent specification.
一般式()(式中、Aは上記定義の通りであ
る)の化合物は容易に、そして下記方法によつて
高収率で製造できることが判つた。 It has been found that compounds of the general formula (), in which A is as defined above, can be prepared easily and in high yields by the method described below.
2,6―ジメチルフエノールをアルカリ性媒体
中でプロピレンオキシドと反応させ得られた化合
物をアシル化し、そして所望ならば、得られた一
般式()(式中、Aはペルハロゲン化低級アル
キルカルボニルオキシ基、低級アルキルスルホニ
ルオキシ基または低級アルキル置換フエニルスル
ホニルオキシ基である)の化合物をアルカリ金属
アジドと反応させる。アミノ化合物を製造しなけ
ればならないなら、得られた1―(2,6―ジメ
チルフエノキシ)―2―アジド―プロパンを還元
する。この後者の化合物はその酸付加塩に転換で
きる。 2,6-dimethylphenol is reacted with propylene oxide in an alkaline medium and the resulting compound is acylated and, if desired, the resulting general formula () (where A is a perhalogenated lower alkylcarbonyloxy group) , a lower alkylsulfonyloxy group, or a lower alkyl-substituted phenylsulfonyloxy group) is reacted with an alkali metal azide. If an amino compound has to be prepared, the 1-(2,6-dimethylphenoxy)-2-azido-propane obtained is reduced. This latter compound can be converted into its acid addition salt.
我々の経験では1―(2,6―ジメチルフエノ
キシ)―2―ヒドロキシ―プロパンは過剰量のプ
ロピレンオキシド及び水溶性の有機溶媒を2,6
―ジメチルフエノールの水溶液に加え、そして得
られた混液を加熱下で撹拌することによつて容易
にかつ良好な収率で製造できることが示された。
アルカリ性薬剤として水酸化ナトリウムもしくは
水酸化カリウムを用いると、出発物質とによる可
溶性のフエノ―レートを形成するので好ましい。
1モルの2,6―ジメチルフエノールについて一
般的には1.05ないし10モル、好ましくは1.2モル
のアルカリを用いる。水溶性の有機溶媒として、
低級アルコールもしくはケトン、アセトニトリ
ル、テトラヒドロフランもしくはジオキサン、好
ましくはエタノールもしくはアセトンを使用でき
る。この反応は20℃ないしこの反応混液の沸点、
好ましくは50ないし60℃の温度で実施できる。所
望ならば、この反応混液を処理した後に得られた
粗製の1―(2,6―ジメチルフエノキシ)―2
―ヒドロキシ―プロパンをこれらの一般式()
(式中、Aはペルハロゲン化低級アルキルカルボ
ニルオキシ基、低級アルキルスルホニルオキシ基
または低級アルキル置換フエニルスルホニルオキ
シ基である)の化合物の製造に直接使用できる。 In our experience, 1-(2,6-dimethylphenoxy)-2-hydroxy-propane can be used to remove excess propylene oxide and water-soluble organic solvents.
- It was shown that it can be easily produced in good yield by adding it to an aqueous solution of dimethylphenol and stirring the resulting mixture under heat.
It is preferable to use sodium hydroxide or potassium hydroxide as the alkaline agent because it forms a soluble phenolate with the starting material.
For every mole of 2,6-dimethylphenol, 1.05 to 10 moles of alkali are generally used, preferably 1.2 moles. As a water-soluble organic solvent,
Lower alcohols or ketones, acetonitrile, tetrahydrofuran or dioxane, preferably ethanol or acetone can be used. This reaction is carried out at 20℃ or the boiling point of this reaction mixture,
Preferably, it can be carried out at a temperature of 50 to 60°C. If desired, the crude 1-(2,6-dimethylphenoxy)-2 obtained after working up this reaction mixture
-Hydroxy-propane with these general formulas ()
(wherein A is a perhalogenated lower alkylcarbonyloxy group, a lower alkylsulfonyloxy group or a lower alkyl-substituted phenylsulfonyloxy group).
本明細書において「低級アルキル」とは炭素原
子1〜4個のアルキルを意味する。 As used herein, "lower alkyl" means alkyl having 1 to 4 carbon atoms.
1―(2,6―ジメチルフエノキシ)―2―ヒ
ドロキシ―プロパンは慣用のアシル化方法によつ
てペルハロゲン化低級アルキルカルボニルオキ
シ、低級アルキルスルホニルオキシまたは低級ア
ルキル置換フエニルスルホニルオキシ誘導体に転
換できる(参照:「Methoden der organischen
Chemie」,Georg Thieme Verlag,1952,第8
巻,543頁)。 1-(2,6-dimethylphenoxy)-2-hydroxy-propane is converted to perhalogenated lower alkylcarbonyloxy, lower alkylsulfonyloxy or lower alkyl substituted phenylsulfonyloxy derivatives by conventional acylation methods. (See also: ``Methoden der organischen''
Chemie”, Georg Thieme Verlag, 1952, No. 8
Volume, page 543).
アシル化反応は10℃以下の温度においてピリジ
ン中、又はジクロロエタン及びトリエチルアミン
の混液中で好ましく実施される。アシル化した化
合物は(98%以上の)すぐれた収率で非常に純粋
な状態で生成される。所望ならば、アシル誘導体
は1―(2,6―ジメチルフエノキシ)―2―ア
ジド―プロパン(式(),A=アジド)の製造
に直接使用できる。 The acylation reaction is preferably carried out in pyridine or in a mixture of dichloroethane and triethylamine at a temperature below 10°C. The acylated compounds are produced in excellent yields (>98%) and in very pure form. If desired, the acyl derivatives can be used directly in the preparation of 1-(2,6-dimethylphenoxy)-2-azido-propane (formula (), A=azido).
アジド化合物は一般式()(式中、Aはペル
ハロゲン化低級アルキルカルボニルオキシ基、低
級アルキルスルホニルオキシ基または低級アルキ
ル置換フエニルスルホニルオキシ基である)の化
合物を金属アジド、好ましくはアジ化ナトリウム
と、水及び水溶性の有機溶媒、好ましくはエチレ
ングリコールモノメチルエーテルもしくはエチレ
ングリコールモノエチルエーテルの存在下で反応
させることによつて製造される。得られた1―
(2,6―ジメチルフエノキシ)―2―アジド―
プロパンは極めて安定であり(蒸留されて、かつ
200℃で加熱したときでさえ分解しない)、良好な
収率(83ないし89%)で形成される。所望なら
ば、この化合物はアミノ誘導体を製造するのに更
に精製することなく直接使用できる。 The azide compound is a compound of the general formula () (in which A is a perhalogenated lower alkylcarbonyloxy group, a lower alkylsulfonyloxy group, or a lower alkyl-substituted phenylsulfonyloxy group), which is a metal azide, preferably sodium azide. and water and a water-soluble organic solvent, preferably ethylene glycol monomethyl ether or ethylene glycol monoethyl ether. Obtained 1-
(2,6-dimethylphenoxy)-2-azido-
Propane is extremely stable (distilled and
(does not decompose even when heated to 200 °C) and is formed in good yields (83 to 89%). If desired, this compound can be used directly without further purification to prepare amino derivatives.
アミノ化合物、即ち、1―(2,6―ジメチル
フエノキシ)―2―アミノ―プロパンはアジド化
合物を公知方法で還元することによつて製造され
る(参照Houben―Weyl「Methoden der
organischen Chemie」Georg Thieme Verlag,
1957 Vol.11/1 第262,539及び1002頁)。還元は
好ましくは接触水添によつて実施される。 Amino compounds, namely 1-(2,6-dimethylphenoxy)-2-amino-propane, are prepared by reducing azide compounds by known methods (see Houben-Weyl, “Methoden der
Organischen Chemie” Georg Thieme Verlag,
1957 Vol. 11/1 No. 262, 539 and 1002). Reduction is preferably carried out by catalytic hydrogenation.
この後者の反応において、1―(2,6―ジメ
チルフエノキシ)―2―アミノ―プロパン塩基は
副生成物を含まない単独の生成物としてほぼ定量
的な収率で得られる。この反応は薄層クロマトグ
ラフイーによつて容易に監視できる。この反応は
実施が容易で、かつ特定の装置を要しない。 In this latter reaction, 1-(2,6-dimethylphenoxy)-2-amino-propane base is obtained as a single product without by-products in an almost quantitative yield. This reaction can be easily monitored by thin layer chromatography. This reaction is easy to perform and does not require special equipment.
本発明による新規な方法は以下に示す下記の重
要な利益をもたらす:
1 全ての出発物質は製造が容易であり、扱い易
く、かつ健康に対し有害でない。 The novel process according to the invention offers the following important benefits: 1. All starting materials are easy to produce, easy to handle and are not harmful to health.
2 この反応は特別の装置を用いないでも容易に
実施でき、かつすぐれた収率で行われる。2 This reaction can be easily carried out without the use of special equipment and is carried out in excellent yields.
3 一般式()の化合物は全て扱いが容易な安
定物質であり、かつ粗製状態でもそれらを引き
続いて転換反応させるのに十分である。3. All compounds of the general formula () are stable substances that are easy to handle, and even their crude state is sufficient for their subsequent conversion reactions.
4 1―(2,6―ジメチルフエノキシ)―2―
アジド―プロパンのアミンへの還元は大気圧
下、室温においてほぼ定量的に実施でき、そし
て純粋な化合物が製造される。4 1-(2,6-dimethylphenoxy)-2-
The reduction of azido-propane to the amine can be carried out almost quantitatively at room temperature under atmospheric pressure and produces pure compounds.
5 1―(2,6―ジメチルフエノキシ)―2―
アミノ―2―プロパンは反応混液から極めて容
易に分離できる。5 1-(2,6-dimethylphenoxy)-2-
Amino-2-propane can be separated very easily from the reaction mixture.
以下に示す例は本発明を説明するためのもので
あり、その範囲を限定するものではない。 The examples given below are intended to illustrate the invention and are not intended to limit its scope.
例 1
1―(2,6―ジメチルフエノキシ)―2―ヒ
ドロキシ―プロパン
2,6―ジメチルフエノール12.2g(0.1モル)
を水20ml中の水酸化ナトリウム4.2g(0.105モ
ル)の溶液に溶かした。この溶液にエタノール25
ml及びプロピレンオキシド8.7g(0.15モル)を
加え、そしてこの混合物を60℃で12時間撹拌し
た。この混合物を冷却し、ベンゼン200ml及び水
200mlを加え、そして有機層を分離した。この水
層をベンゼン200mlで抽出した。これらのベンゼ
ン溶液を合併し、水200mlで洗浄し、硫酸ナトリ
ウム上で乾燥し、そして水蒸気浴から減圧下(40
mmHg)で蒸発乾固した。油状物質14.6g(81
%)を得た。この粗製の生成物は例2ないし5に
記載のアシル化反応において直接使用できた。こ
の粗製の1―(2,6―ジメチルフエノキシ)―
2―ヒドロキシ―プロパンは蒸留して精製できる
(沸点84℃)。Rf=0.6(ベンゼン及びピリジンの
6:1の混液中の0.1ないし0.3mm厚のメルクグレ
ードのシリカゲル層でのクロマトグラフイー;塩
素化後のo―トルイジンで展開。参照「Z・
Anal.Chem.」148,181(1955))。Example 1 1-(2,6-dimethylphenoxy)-2-hydroxy-propane 2,6-dimethylphenol 12.2g (0.1 mol)
was dissolved in a solution of 4.2 g (0.105 mol) of sodium hydroxide in 20 ml of water. Ethanol 25% to this solution
ml and 8.7 g (0.15 mol) of propylene oxide were added and the mixture was stirred at 60° C. for 12 hours. Cool this mixture, add 200ml of benzene and water.
200ml was added and the organic layer was separated. This aqueous layer was extracted with 200 ml of benzene. These benzene solutions were combined, washed with 200 ml of water, dried over sodium sulfate, and dried under reduced pressure (40 ml) from a steam bath.
evaporated to dryness (mmHg). Oily substance 14.6g (81
%) was obtained. This crude product could be used directly in the acylation reactions described in Examples 2-5. This crude 1-(2,6-dimethylphenoxy)-
2-Hydroxy-propane can be purified by distillation (boiling point 84°C). R f = 0.6 (chromatography on a layer of Merck grade silica gel 0.1 to 0.3 mm thick in a 6:1 mixture of benzene and pyridine; developed with o-toluidine after chlorination; see Z.
Anal. Chem.” 148 , 181 (1955)).
分析 C11H16O2(分子量=180.24)
計算値 C:73.30% H:8.95%
測定値 C:73.60% H:9.07%
例 2
1―2,6―ジメチルフエノキシ)―2―(4
―メチルフエニルスルホニルオキシ)―プロパ
ン
例1に記載のようにして得た粗製の1―(2,
6―ジメチルフエノキシ)―2―ヒドロキシ―プ
ロパン9.0g(0.05モル)を乾燥ピリジン50mlに
溶かし、そして19.0g(0.1モル)の塩化トシル
を氷で冷却しながらこの溶液に少しずつ加えた。
この添加の間、この混液の温度を10℃以下に保つ
べきである。添加が完了したとき、冷却浴をはず
し、この混液を20ないし25℃に放置して温めて、
そして同温度で1時間撹拌した。この反応の終了
時にこの混液を砕いた氷100g上に注ぎ、そして
この生成物をベンゼン200mlで抽出した。このベ
ンゼン溶液を水洗し、硫酸ナトリウム上で乾燥
し、そして真空中で蒸発乾固した。得られた結晶
残渣をイソプロパノール20mlから再結晶させて
16.5g(98.7g)の1―(2,6―ジメチルフエ
ノキシ)―2―(4―メチル―フエニルスルホニ
ルオキシ)―プロパン(融点63―64℃)を生成し
た。融点が59―61℃の粗製の生成物は例6に記載
の反応中で直接使用できた。Analysis C 11 H 16 O 2 (Molecular weight = 180.24) Calculated value C: 73.30% H: 8.95% Measured value C: 73.60% H: 9.07% Example 2 1-2,6-dimethylphenoxy)-2-(4
-methylphenylsulfonyloxy)-propane The crude 1-(2,
9.0 g (0.05 mol) of 6-dimethylphenoxy)-2-hydroxy-propane were dissolved in 50 ml of dry pyridine and 19.0 g (0.1 mol) of tosyl chloride was added portionwise to this solution while cooling with ice.
During this addition, the temperature of the mixture should be kept below 10°C. When the addition is complete, remove the cooling bath and allow the mixture to warm to 20-25°C.
The mixture was stirred at the same temperature for 1 hour. At the end of the reaction, the mixture was poured onto 100 g of crushed ice and the product was extracted with 200 ml of benzene. The benzene solution was washed with water, dried over sodium sulphate and evaporated to dryness in vacuo. The obtained crystal residue was recrystallized from 20 ml of isopropanol.
16.5g (98.7g) of 1-(2,6-dimethylphenoxy)-2-(4-methyl-phenylsulfonyloxy)-propane (melting point 63-64°C) was produced. The crude product with a melting point of 59-61°C could be used directly in the reaction described in Example 6.
Rf=0.8(ベンゼン及びピリジンの6:1混液中
の0.1ないし0.3mm厚のメルクグレードのシリカゲ
ル層でのクロマトグラフイー、塩素化後のo―ト
ルイジンによる展開)。 R f =0.8 (chromatography on a layer of Merck grade silica gel 0.1 to 0.3 mm thick in a 6:1 mixture of benzene and pyridine, developed with o-toluidine after chlorination).
分析 C18H22SO4(分子量334.42)
計算値 C:64.64% H:6.63% S:9.59%
測定値 C:64.84% H:6.86% S:9.86%
例 3
1―(2,6―ジメチルフエノキシ)―2―メ
タンスルホニルオキシ―プロパン
例2に記載のように操作した。ただし、1―
(2,6―ジメチルフエノキシ)―2―ヒドロキ
シ―プロパンのピリジン溶液に塩化メシル11.4g
(0.1モル)を滴加した。この反応混液を例2に記
載のようにして処理し、そして蜂蜜様の粘性の物
質として1―(2,6―ジメチルフエノキシ)―
2―メタンスルホニルオキシ―プロパン12.8g
(99.1%)を生成した。この粗製の生成物は例7
に記載の反応中で直接使用できる。Analysis C 18 H 22 SO 4 (molecular weight 334.42) Calculated value C: 64.64% H: 6.63% S: 9.59% Measured value C: 64.84% H: 6.86% S: 9.86% Example 3 1-(2,6-dimethyl fluoride) (enoxy)-2-methanesulfonyloxy-propane Worked as described in Example 2. However, 1-
Mesyl chloride 11.4g in pyridine solution of (2,6-dimethylphenoxy)-2-hydroxy-propane
(0.1 mol) was added dropwise. The reaction mixture was worked up as described in Example 2 and 1-(2,6-dimethylphenoxy)-
2-methanesulfonyloxy-propane 12.8g
(99.1%). This crude product is Example 7
can be used directly in the reactions described in .
Rf=0.8(ベンゼン及びピリジンの6:1混液中
の0.1ないし0.3mm厚のメルクグレードのシリカゲ
ル層におけるクロマトグラフイー、塩素化後にo
―トルイジンで展開)
分析 C12H18O4S(分子量258.33)
計算値 C:55.78% H:7.02% S:12.41%
測定値 C:56.20% H:7.52% S:12.14%
例 4
1―(2,6―ジメチルフエノキシ)―2―ト
リクロロアセチルオキシ―プロパン
例2に記載のように操作を行つた。ただし、そ
の違いとして1―(2,6―ジメチルフエノキ
シ)―2―ヒドロキシ―プロパンのピリジン溶液
にトリクロロアセチルクロリド18.1g(0.1モル)
を滴加した。この反応混液を例2に記載のように
処理して、粗製の油状1―(2,6―ジメチルフ
エノキシ)―2―トリクロロアセチルオキシ―プ
ロパン16.1g(98.9%)を生成したが、これは例
8に記載の処理において精製せずに適用できた。
この生成物は蒸留精製できた。(沸点146℃/0.4
mmHg)
Rf=0.85(ベンゼン及びピリジンの6:1混液
中の0.1ないし0.3mm厚のメルクグレードのシリカ
ゲル層でのクロマトグラフイー:塩素化後にo―
トルイジンで展開)
分析 C13H15Cl3O3(分子量325.62)
計算値 C:47.95% H:4.64%
Cl:32.67%
測定値 C:48.12% H:4.92%
Cl:32.48%
例 5
1―(2,6―ジメチルフエノキシ)―2―
(4―メチル―フエニルスルホニルオキシ)―
プロパン
トリエチルアミン11.1g(0.11モル)を例1に
記載のようにして得られた粗製の1―(2,6―
ジメチルフエノキシ)―2―ヒドロキシ―プロパ
ン9.0g(0.05モル)の乾燥ジクロロエタン100ml
中の溶液に加えた。この溶液を氷冷下で撹拌し、
そして乾燥ジクロロエタン50ml中の塩化トシル
19.0g(0.1モル)の溶液に滴加した。添加が完
了したとき、冷却浴をはずし、この反応混液を20
ないし25℃にあたためておき、そして同温度で1
時間撹拌した。この反応の終了時に、この混液を
砕いた氷100gで分解し、そして層を互に分離し
た。このジクロロエタン層を水洗し、硫酸ナトリ
ウム上で乾燥し、そして真空中で蒸発乾固した。
結晶残渣を例2に記載のように再結晶させて
16.55g(98.9%)の1―(2,6―ジメチルフ
エノキシ)―2―(4―メチル―フエニルスルホ
ニルオキシ)―プロパン(融点58―61℃)を得
た。この化合物は例2によつて得られた生成物と
一致しており、そして例6に記載の反応に直接用
いることができた。 R f = 0.8 (chromatography on a 0.1 to 0.3 mm thick layer of Merck grade silica gel in a 6:1 mixture of benzene and pyridine, o
-Developed with toluidine) Analysis C 12 H 18 O 4 S (molecular weight 258.33) Calculated value C: 55.78% H: 7.02% S: 12.41% Measured value C: 56.20% H: 7.52% S: 12.14% Example 4 1-( 2,6-Dimethylphenoxy)-2-trichloroacetyloxy-propane The procedure was carried out as described in Example 2. However, the difference is that 18.1 g (0.1 mol) of trichloroacetyl chloride is added to the pyridine solution of 1-(2,6-dimethylphenoxy)-2-hydroxy-propane.
was added dropwise. The reaction mixture was worked up as described in Example 2 to yield 16.1 g (98.9%) of crude oily 1-(2,6-dimethylphenoxy)-2-trichloroacetyloxy-propane, which could be applied without purification in the treatment described in Example 8.
This product could be purified by distillation. (boiling point 146℃/0.4
mmHg) R f = 0.85 (chromatography on a 0.1 to 0.3 mm thick layer of Merck grade silica gel in a 6:1 mixture of benzene and pyridine: after chlorination o-
Analysis C 13 H 15 Cl 3 O 3 (molecular weight 325.62) Calculated value C: 47.95% H: 4.64% Cl: 32.67% Measured value C: 48.12% H: 4.92% Cl: 32.48% Example 5 1-( 2,6-dimethylphenoxy)-2-
(4-methyl-phenylsulfonyloxy)-
11.1 g (0.11 mol) of propane triethylamine were added to the crude 1-(2,6-
9.0 g (0.05 mol) of dimethylphenoxy)-2-hydroxy-propane in 100 ml of dry dichloroethane
Added to the solution inside. This solution was stirred under ice cooling,
and tosyl chloride in 50 ml of dry dichloroethane.
It was added dropwise to a solution of 19.0 g (0.1 mol). When the addition is complete, remove the cooling bath and cool the reaction mixture for 20
Warm it to 25℃ or 25℃, and then heat it at the same temperature.
Stir for hours. At the end of the reaction, the mixture was decomposed with 100 g of crushed ice and the layers were separated from each other. The dichloroethane layer was washed with water, dried over sodium sulfate and evaporated to dryness in vacuo.
The crystalline residue was recrystallized as described in Example 2.
16.55 g (98.9%) of 1-(2,6-dimethylphenoxy)-2-(4-methyl-phenylsulfonyloxy)-propane (melting point 58-61°C) was obtained. This compound corresponds to the product obtained according to Example 2 and could be used directly in the reaction described in Example 6.
例 6
1―(2,6―ジメチルフエノキシ)―2―ア
ジド―プロパン
例2もしくは5に記載のように製造した粗製の
1―(2,6―ジメチルフエノキシ)―2―(4
―メチル―フエニルスルホニルオキシ)―プロパ
ン8.36g(0.025モル)をエチレングリコールモ
ノメチルエーテル50mlに溶かした。水15ml中のア
ジ化ナトリウム3.25g(0.05モル)の溶液を一度
に加えて得られた混液を5時間還流した。この混
液を放冷し、水100ml及びクロロホルム100mlと混
ぜ、そして有機層を分離した。このクロロホルム
溶液を水200mlで洗い、硫酸ナトリウム上で乾燥
し、そして蒸気浴上減圧下(40ないし60mmHg)
で蒸発乾固した。粗製の1―(2,6―ジメチル
フエノキシ)―2―アジド―プロパン4.6g
(89.6%)を得たが、これは例9に記載の反応に
おいて直接通用できた。この生成物を蒸留精製し
た。(沸点106℃/0.7mmHg)
Rf=0.75(ベンゼン及びピリジンの6:1混液
中の0.1ないし0.3mm厚のメルクグレードのシリカ
ゲル層によるクロマトグラフイー;塩素化後o―
トルイジンで展開)
分析 C11H15N3O(分子量:205.25)
計算値 C:64.37% H:7.37% N:20.47%
測定値 C:64.65% H:7.48% N:20.30%
例 7
1―(2,6―ジメチルフエノキシ)―2―ア
ジド―プロパン
例6に記載のように操作した。ただし、例3に
記載のようにして得た粗製の1―(2,6―ジメ
チルフエノキシ)―2―メタンスルホニルオキ
シ)―プロパン6.46g(0.025モル)を1―(2,
6―ジメチルフエノキシ)―2―(4―メチル―
フエニルスルホニルオキシ)―プロパンの代わり
に出発物質として用いた。この反応混液を例6に
記載のように処理して粗製の1―(2,6―ジメ
チルフエノキシ)―2―アジド―プロパン4.3g
(83.8%)を得たが、これは例6によつて得た生
成物と同じであつた。Example 6 1-(2,6-dimethylphenoxy)-2-azido-propane Crude 1-(2,6-dimethylphenoxy)-2-(4
-Methyl-phenylsulfonyloxy)-propane (8.36 g (0.025 mol)) was dissolved in 50 ml of ethylene glycol monomethyl ether. A solution of 3.25 g (0.05 mol) of sodium azide in 15 ml of water was added in one portion and the resulting mixture was refluxed for 5 hours. The mixture was allowed to cool, mixed with 100 ml of water and 100 ml of chloroform, and the organic layer was separated. The chloroform solution was washed with 200 ml of water, dried over sodium sulfate, and dried on a steam bath under reduced pressure (40 to 60 mm Hg).
It was evaporated to dryness. 4.6 g of crude 1-(2,6-dimethylphenoxy)-2-azido-propane
(89.6%), which could be used directly in the reaction described in Example 9. This product was purified by distillation. (boiling point 106°C/0.7 mmHg) R f =0.75 (chromatography on a layer of Merck grade silica gel 0.1 to 0.3 mm thick in a 6:1 mixture of benzene and pyridine; after chlorination o-
Analysis C 11 H 15 N 3 O (molecular weight: 205.25) Calculated value C: 64.37% H: 7.37% N: 20.47% Measured value C: 64.65% H: 7.48% N: 20.30% Example 7 1-( 2,6-dimethylphenoxy)-2-azido-propane Worked as described in Example 6. However, 6.46 g (0.025 mol) of crude 1-(2,6-dimethylphenoxy)-2-methanesulfonyloxy)-propane obtained as described in Example 3 was added
6-dimethylphenoxy)-2-(4-methyl-
phenylsulfonyloxy)-propane was used as the starting material instead. This reaction mixture was treated as described in Example 6 to yield 4.3 g of crude 1-(2,6-dimethylphenoxy)-2-azido-propane.
(83.8%), which was the same as the product obtained according to Example 6.
例 8
1―(2,6―ジメチルフエノキシ)―2―ア
ジド―プロパン
例6に記載のように処理した。ただし、1―
(2,6―ジメチルフエノキシ)―2―(4―メ
チル―フエニルスルホニルオキシ)―プロパンの
代わりに、例4で調製した粗製の1―(2,6―
ジメチルフエノキシ)―2―トリクロロアセチル
オキシ―プロパン8.14g(0.025モル)を出発物
質として用いた。この反応混液を例6に記載のよ
うに処理して粗製の1―(2,6―ジメチルフエ
ノキシ)―2―アジド―プロパン4.5g(87.7%)
を得たがこれは例6によつて得た生成物と一致し
ていた。Example 8 1-(2,6-dimethylphenoxy)-2-azido-propane Treated as described in Example 6. However, 1-
(2,6-dimethylphenoxy)-2-(4-methyl-phenylsulfonyloxy)-propane was replaced with the crude 1-(2,6-
8.14 g (0.025 mol) of dimethylphenoxy)-2-trichloroacetyloxy-propane was used as starting material. The reaction mixture was treated as described in Example 6 to yield 4.5 g (87.7%) of crude 1-(2,6-dimethylphenoxy)-2-azido-propane.
was obtained, which was consistent with the product obtained according to Example 6.
例 9
1―(2,6―ジメチルフエノキシ)―2―ア
ミノ―プロパン塩酸塩
木炭担持パラジウム触媒1gを例6ないし8の
いずれかで製造した粗製の1―(2,6―ジメチ
ルフエノキシ)―2―アジド―プロパン4.1g
(0.02モル)のエタノール100ml中の溶液に加え
た。水素をゆつくり泡立ててフラスコ中を連続的
に通し、そしてこの混合物を20ないし25℃におい
て5時間振盪させて水添付加した。この反応の進
行はベンゼン及びピリジンの6:1混液中の0.1
ないし0.3mm厚のトルクグレードのシリカゲル層
におけるクロマトグラフイーによつて監視した。
スポツトは塩素化後o―トルイジンで展開した。Example 9 1-(2,6-dimethylphenoxy)-2-amino-propane hydrochloride 1 g of charcoal-supported palladium catalyst was added to the crude 1-(2,6-dimethylphenoxy)-2-amino-propane hydrochloride prepared in any of Examples 6 to 8. C)-2-azido-propane 4.1g
(0.02 mol) in 100 ml of ethanol. Hydrogen was slowly bubbled continuously through the flask and the mixture was shaken at 20-25°C for 5 hours before adding water. This reaction progresses with 0.1
Monitored by chromatography on a layer of torque grade silica gel from 0.3 to 0.3 mm thick.
The spots were developed with o-toluidine after chlorination.
この反応の終了時に触媒を過除去し、そして
少量の70%水性エタノールで洗つた。この液を
濃塩酸でPH=1に酸性化し、そして次に蒸気浴
上、減圧(40mmHg)下で蒸発乾固した。得られ
た粗製の1―(2,6―ジメチルフエノキシ)―
2―アミノ―プロパン塩酸塩結晶4.4g(100%)
を加熱下でイソプロパノール10mlに溶かし、この
溶液を過し、そして約40℃でこの液に乾燥エ
ーテル50mlを加えたところ、生成物は結晶化しは
じめた。この混合物を氷冷し、結晶を過し、少
量のエーテルで洗い、そして乾燥した。得られた
精製した1―(2,6―ジメチルフエノキシ)―
2―アミノ―プロパン塩酸塩は201―203℃で溶け
た。 At the end of the reaction the catalyst was filtered off and washed with a small amount of 70% aqueous ethanol. The solution was acidified to PH=1 with concentrated hydrochloric acid and then evaporated to dryness under reduced pressure (40 mm Hg) on a steam bath. The obtained crude 1-(2,6-dimethylphenoxy)-
2-amino-propane hydrochloride crystals 4.4g (100%)
was dissolved in 10 ml of isopropanol under heating, the solution was filtered, and 50 ml of dry ether was added to the liquid at about 40° C., and the product began to crystallize. The mixture was cooled on ice, the crystals were filtered, washed with a little ether and dried. The obtained purified 1-(2,6-dimethylphenoxy)-
2-Amino-propane hydrochloride melted at 201-203°C.
Claims (1)
ボニルオキシ基、低級アルキルスルホニルオキシ
基、低級アルキル置換フエニルスルホニルオキシ
基またはアジド基である)の化合物。 2 1―(2,6―ジメチルフエノキシ)―2―
(4―メチル―フエニルスルホニルオキシ)―プ
ロパンである特許請求の範囲第1項記載の化合
物。 3 1―(2,6―ジメチルフエノキシ)―2―
メタンスルホニルオキシ―プロパンである特許請
求の範囲第1項記載の化合物。 4 1―(2,6―ジメチルフエノキシ)―2―
トリクロロアセチルオキシプロパンである特許請
求の範囲第1項記載の化合物。 5 1―(2,6―ジメチルフエノキシ)―2―
アジド―プロパンである特許請求の範囲第1項記
載の化合物。 6 一般式() (式中、Aはペルハロゲン化低級アルキルカル
ボニルオキシ基、低級アルキルスルホニルオキシ
基、低級アルキル置換フエニルスルホニルオキシ
基またはアジド基を示す)の化合物を製造するに
当たり、1―(2,6―ジメチルフエノキシ)―
2―ヒドロキシ―プロパンをアシル化またはスル
ホン化し、そして所望により、得られた一般式
()(式中、Aはペルハロゲン化低級アルキルカ
ルボニルオキシ基、低級アルキルスルホニルオキ
シ基または低級アルキル置換フエニルスルホニル
オキシ基である)の化合物とアルカリ金属アジド
とを反応させることを特徴とする、前記一般式
()の化合物の製造。[Claims] 1 General formula () (wherein A is a perhalogenated lower alkylcarbonyloxy group, a lower alkylsulfonyloxy group, a lower alkyl-substituted phenylsulfonyloxy group, or an azido group). 2 1-(2,6-dimethylphenoxy)-2-
The compound according to claim 1, which is (4-methyl-phenylsulfonyloxy)-propane. 3 1-(2,6-dimethylphenoxy)-2-
The compound according to claim 1, which is methanesulfonyloxy-propane. 4 1-(2,6-dimethylphenoxy)-2-
The compound according to claim 1, which is trichloroacetyloxypropane. 5 1-(2,6-dimethylphenoxy)-2-
The compound according to claim 1, which is azido-propane. 6 General formula () (In the formula, A represents a perhalogenated lower alkylcarbonyloxy group, a lower alkylsulfonyloxy group, a lower alkyl-substituted phenylsulfonyloxy group, or an azido group). phenoxy) -
2-Hydroxy-propane is acylated or sulfonated, and optionally the resulting general formula ( Production of a compound of the general formula (), which is characterized by reacting the compound (which is an oxy group) with an alkali metal azide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU78GO1401A HU176102B (en) | 1978-04-28 | 1978-04-28 | Process for preparing phenylethers |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5547641A JPS5547641A (en) | 1980-04-04 |
JPS6338979B2 true JPS6338979B2 (en) | 1988-08-03 |
Family
ID=10996855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5157979A Granted JPS5547641A (en) | 1978-04-28 | 1979-04-27 | Phenylether compound and its manufacture |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS5547641A (en) |
AT (1) | AT365169B (en) |
CA (1) | CA1132598A (en) |
CS (1) | CS208498B2 (en) |
DD (1) | DD143249A1 (en) |
DE (1) | DE2917178A1 (en) |
DK (1) | DK166820B1 (en) |
ES (1) | ES479867A1 (en) |
FI (1) | FI791340A (en) |
HU (1) | HU176102B (en) |
IL (1) | IL57080A (en) |
IN (1) | IN150039B (en) |
NO (1) | NO148450C (en) |
PL (3) | PL125109B1 (en) |
SU (3) | SU980614A3 (en) |
YU (1) | YU41861B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5932685A (en) * | 1982-08-16 | 1984-02-22 | Hitachi Constr Mach Co Ltd | Capacity controller for variable capacity pump |
JPS60146713U (en) * | 1984-03-09 | 1985-09-28 | 株式会社 名機製作所 | Injection molding machine with hydraulic oil heating circuit |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1643240A1 (en) * | 1966-09-16 | 1971-06-24 | Boehringer Sohn Ingelheim | Process for the preparation of new racemic or optically active 1-phenoxy-2-aminoalkanes |
-
1978
- 1978-04-28 HU HU78GO1401A patent/HU176102B/en unknown
-
1979
- 1979-04-16 IN IN368/CAL/79A patent/IN150039B/en unknown
- 1979-04-16 IL IL57080A patent/IL57080A/en unknown
- 1979-04-24 CS CS792855A patent/CS208498B2/en unknown
- 1979-04-24 ES ES479867A patent/ES479867A1/en not_active Expired
- 1979-04-25 FI FI791340A patent/FI791340A/en not_active Application Discontinuation
- 1979-04-25 YU YU996/79A patent/YU41861B/en unknown
- 1979-04-26 PL PL1979225752A patent/PL125109B1/en unknown
- 1979-04-26 DD DD79212518A patent/DD143249A1/en unknown
- 1979-04-26 SU SU792760454A patent/SU980614A3/en active
- 1979-04-26 PL PL1979225751A patent/PL126968B1/en unknown
- 1979-04-26 AT AT0312379A patent/AT365169B/en not_active IP Right Cessation
- 1979-04-26 DK DK172679A patent/DK166820B1/en active IP Right Grant
- 1979-04-26 PL PL21518179A patent/PL215181A1/xx unknown
- 1979-04-27 CA CA326,489A patent/CA1132598A/en not_active Expired
- 1979-04-27 NO NO791412A patent/NO148450C/en unknown
- 1979-04-27 DE DE19792917178 patent/DE2917178A1/en active Granted
- 1979-04-27 JP JP5157979A patent/JPS5547641A/en active Granted
-
1980
- 1980-05-23 SU SU802925098A patent/SU978724A3/en active
- 1980-05-23 SU SU802925097A patent/SU980616A3/en active
Also Published As
Publication number | Publication date |
---|---|
PL125109B1 (en) | 1983-03-31 |
CS208498B2 (en) | 1981-09-15 |
AT365169B (en) | 1981-12-28 |
JPS5547641A (en) | 1980-04-04 |
SU980614A3 (en) | 1982-12-07 |
DE2917178C2 (en) | 1989-01-12 |
YU99679A (en) | 1982-10-31 |
FI791340A (en) | 1979-10-29 |
HU176102B (en) | 1980-12-28 |
NO791412L (en) | 1979-10-30 |
DD143249A1 (en) | 1980-08-13 |
ATA312379A (en) | 1981-05-15 |
IN150039B (en) | 1982-07-03 |
NO148450C (en) | 1983-10-12 |
YU41861B (en) | 1988-02-29 |
SU978724A3 (en) | 1982-11-30 |
IL57080A0 (en) | 1979-07-25 |
PL215181A1 (en) | 1980-01-28 |
SU980616A3 (en) | 1982-12-07 |
NO148450B (en) | 1983-07-04 |
DE2917178A1 (en) | 1979-11-08 |
IL57080A (en) | 1983-05-15 |
CA1132598A (en) | 1982-09-28 |
ES479867A1 (en) | 1980-08-16 |
DK166820B1 (en) | 1993-07-19 |
DK172679A (en) | 1979-10-29 |
PL126968B1 (en) | 1983-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0178874B1 (en) | Alkylsulfonamidophenylalkylamines | |
US5464872A (en) | Arylalkyl (thio) amides | |
JP2655692B2 (en) | Sulfonamidothienylcarboxylic acid compound | |
JP2637737B2 (en) | New drugs | |
JPS59108749A (en) | Manufacture of 5-((r)-1-hydroxy-2-((r)-(1-methyl-3 -phenylpropyl)amino)ethyl)salicylamide or pharmacologically acceptable acid addition salt | |
SU623518A3 (en) | Method of obtaining oxazole derivatives | |
CA2060326C (en) | Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides | |
US4596827A (en) | Alkylsulfonamidophenylalkylamine compounds used for treating arrhythmia | |
US4129656A (en) | Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them | |
JPS6338979B2 (en) | ||
JPS5839820B2 (en) | Method for producing serinol and serinol derivatives | |
CA1042905A (en) | Preparation of new bisubstituted azabicycloalkans_ | |
US4511566A (en) | 2-N-Cycloalkylmethyl 3-oxo 5,6-diaryl-as-triazines | |
EP0713865B1 (en) | 2-Aminobenzenesulphonic acid and 2-aminobenzenesulphonyl chloride derivatives, their preparation and their use as synthetic intermediates | |
US2623065A (en) | Methods for producing alkoxynaphthoylalkanoic acids | |
CA1044697A (en) | Novel disubstituted azabicycloalcanes | |
EP0132267A1 (en) | Aromatic amines. | |
BE858864A (en) | NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION | |
SU741796A3 (en) | Method of preparing substituted n-/2-(furyl-2)-ethyl/-propynylamines or their salts, or their optical isomers | |
CA1078837A (en) | Active derivatives of methylamine, therapeutic compositions containing the same and processes for preparing the said derivatives and compositions | |
JPS5839145B2 (en) | 2↓-[N↓-(2↓-hydroxyethyl)↓-N↓-lower alkylaminomethyl]↓-benzhydrol production method | |
CS246205B1 (en) | Method of aryloxypropanolamines' n-hydroxyderivatives preparation | |
FR2536393A1 (en) | New aminoketones, process for preparing them and their therapeutic use | |
DK145041B (en) | METHOD OF ANALOGUE FOR PREPARING A BENZOPHENO DERIVATIVE OR ACID ADDITION SALTS THEREOF | |
CH433241A (en) | Process for preparing diphenylacetamides |